Pierre Vantourout

12PUBLICATIONS
186CO-AUTHORS
Medical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 22, 2024
Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C).

Evangelos Bellos, Dilys Santillo, Pierre Vantourout

|Dec 06, 2023
Innate TCRβ-chain engagement drives human T cells toward distinct memory-like effector phenotypes with immunotherapeutic potentials.

Pierre Vantourout, Josephine Eum, María Conde Poole

|Sep 14, 2023
Conserved γδ T cell selection by BTNL proteins limits progression of human inflammatory bowel disease.

Robin J Dart, Iva Zlatareva, Pierre Vantourout

|Jun 13, 2023
β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer.

Toshiyasu Suzuki, Anna Kilbey, Nuria Casa-Rodríguez

|Aug 09, 2022
Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19.

Magdalene Joseph, Yin Wu, Richard Dannebaum

|Nov 28, 2020
Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis.

Adam G Laing, Anna Lorenc, Irene Del Molino Del Barrio

Pageof 2

Frequent Collaborators

12 joint publications

Adrian Hayday

5 joint publications

Yin Wu

5 joint publications

Leticia Monin

4 joint publications

Lauren Martinez